PMC:7253235 / 1215-1559 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"41","span":{"begin":24,"end":46},"obj":"Disease"},{"id":"42","span":{"begin":51,"end":57},"obj":"Disease"},{"id":"43","span":{"begin":144,"end":150},"obj":"Disease"},{"id":"44","span":{"begin":220,"end":253},"obj":"Disease"},{"id":"45","span":{"begin":302,"end":310},"obj":"Disease"},{"id":"65","span":{"begin":321,"end":333},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:D002318"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:D009369"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D009369"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D002318"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:C000657245"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D006973"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" as the layered risk of cardiovascular disease and cancer. Immunomodulatory therapies used to treat cytokine release syndrome secondary to anti-cancer therapies, as well as other agents being traditionally used to treat cardiovascular and cancer disease states, are being investigated for treatment of COVID-19.\n\nSummary\nHypertension, cardiovas"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":100,"end":108},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":" as the layered risk of cardiovascular disease and cancer. Immunomodulatory therapies used to treat cytokine release syndrome secondary to anti-cancer therapies, as well as other agents being traditionally used to treat cardiovascular and cancer disease states, are being investigated for treatment of COVID-19.\n\nSummary\nHypertension, cardiovas"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":24,"end":46},"obj":"Disease"},{"id":"T13","span":{"begin":51,"end":57},"obj":"Disease"},{"id":"T14","span":{"begin":144,"end":150},"obj":"Disease"},{"id":"T15","span":{"begin":220,"end":245},"obj":"Disease"},{"id":"T16","span":{"begin":239,"end":245},"obj":"Disease"},{"id":"T17","span":{"begin":302,"end":310},"obj":"Disease"},{"id":"T19","span":{"begin":321,"end":333},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0002100"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"}],"text":" as the layered risk of cardiovascular disease and cancer. Immunomodulatory therapies used to treat cytokine release syndrome secondary to anti-cancer therapies, as well as other agents being traditionally used to treat cardiovascular and cancer disease states, are being investigated for treatment of COVID-19.\n\nSummary\nHypertension, cardiovas"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":24,"end":46},"obj":"Phenotype"},{"id":"T9","span":{"begin":51,"end":57},"obj":"Phenotype"},{"id":"T10","span":{"begin":100,"end":125},"obj":"Phenotype"},{"id":"T11","span":{"begin":144,"end":150},"obj":"Phenotype"},{"id":"T12","span":{"begin":239,"end":245},"obj":"Phenotype"},{"id":"T13","span":{"begin":321,"end":333},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0001626"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":" as the layered risk of cardiovascular disease and cancer. Immunomodulatory therapies used to treat cytokine release syndrome secondary to anti-cancer therapies, as well as other agents being traditionally used to treat cardiovascular and cancer disease states, are being investigated for treatment of COVID-19.\n\nSummary\nHypertension, cardiovas"}

{"project":"LitCovid-sentences","denotations":[{"id":"T13","span":{"begin":59,"end":311},"obj":"Sentence"},{"id":"T14","span":{"begin":313,"end":320},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" as the layered risk of cardiovascular disease and cancer. Immunomodulatory therapies used to treat cytokine release syndrome secondary to anti-cancer therapies, as well as other agents being traditionally used to treat cardiovascular and cancer disease states, are being investigated for treatment of COVID-19.\n\nSummary\nHypertension, cardiovas"}